Selected innate, non-immunoglobulin defense factors in canine saliva were characterized and quantitated. The samples from dogs showed increased pH, higher lysozyme and salivary peroxidase activities, but lower hypothiocyanite concentration and myeloperoxidase activity when compared with human saliva. Secondly, a 1-month clinical pilot study was performed using a commercial tooth gel to determine acute and long-term changes in salivary host defense proteins. Daily application of the tooth gel did not substantially affect the concentrations of these factors in dogs with normal salivation. Our results suggest that canine saliva may be similar to human saliva, comprised of both immune and non-immune antimicrobial factors. However, as in humans, oral administration of antimicrobial proteins as reported here does not seem to benefit dogs with normal saliva secretion. Products such as the tooth gel evaluated in this study may benefit dogs with xerostomia or other clinical conditions causing decreased saliva production.
Get full access to this article
View all access options for this article.
References
1.
JimínezABarreraRLopezRManeMCRodriquesJMolledaJM. Immunoglobulin identification and quantification in parotid saliva in dogs. Acta Med Vet1991; 37: 175–183.
2.
BrandtzaegP. Salivary immunoglobulins. In: TenovuoJ, ed. Human saliva: Clinical chemistry and microbiology, Vol II, Boca Raton, FL:CRC Press Inc, 1989; 1–54.
3.
TenovuoJ. Antimicrobial function of human saliva – how important is it for oral health?Acta Odontol Scand1998;56: 250–256.
4.
RudneyJD. Does variability in salivary protein concentrations Influence oral microbial ecology and oral health?Crit Rev Oral Biol Med. 1995; 6:343–367.
5.
MorrisonMAllenPZBrightJ. Lactoperoxidase. V. Identification and isolation of lactoperoxidase from salivary gland. Arch Biochem Biophys1965;111: 126–133.
6.
StephensSHarknessRACockleSM. Lactoperoxidase activity in guinea pig milk and saliva: Correlation in milk of lactoperoxidase with bactericidal activity against Escherichia coli. Br J Exp Pathol1979; 60: 252–258.
7.
MäkinenKKTenovuoJBowenWH. Lactoperoxidases of monkey saliva. Acta Chem Scand1978; B32: 387–389.
8.
HartBLPowellKL. Antibacterial properties of saliva: Role in maternal periparturient grooming and in licking wounds. Physiol Behav1990; 48: 383–386.
9.
Månsson-RahemtullaBBaldoneDCPruittKM. Specific assays for peroxidases in human saliva. Arch Oral Biol1986; 31: 661–668.
10.
LowryOHRosebroughNJFarrALRandallRJ. Protein measurement with the Folin phenol reagent. J Biol Chem1951; 193: 265–275.
11.
AuneTMThomasEL. Accumulation of hypothiocyanite ion during peroxidase-catalyzed oxidation of thiocyanate ion. Eur J Biochem1977; 80: 209–214.
12.
PruittKMTenovuoJMånsson-RahemtullaB. Is thiocyanate peroxidation at equilibrium in vivo?Biochim Biophys Acta1986; 870: 385–391.
13.
BettsRHDaintonFS. Electron transfer and other processes involved in the spontaneous bleaching of acidified solutions of ferric thiocyanate. J Am Chem Soc1953; 75:5721–5727.
14.
HerreraJLLyonsMFIIJohnsonLF. Saliva: Its role in health and disease. J Clin Gastroenterol1988;10: 569–578.
15.
TenovuoJGråhnELehtonenOP. Antimicrobial factors in saliva: Ontogeny and relation to oral health. J Dent Res1987; 66: 475–479.
16.
MandelID. The functions of saliva. J Dent Res1987;66 (Spec Iss): 623–627.
17.
KirstiläVHäkkinenPJentschH. Longitudinal analysis of the association of human salivary antimicrobial factors to caries increment and cariogenic microorganisms: A 2-year cohort study. J Dent Res1998; 77: 73–80.
18.
TenovuoJLehtonenO-PAaltonenAS. Antimicrobial factors in whole saliva of human infants. Infect Immun1986; 51: 49–53.
ViljaPLumikariMTenovuoJ. Sensitive immunometric assays for secretory peroxidase and myeloperoxidase in human saliva. J Immunol Methods1991; 141:277–284.
21.
KirstiläVTenovuoJRuuskanenO. Longitudinal analysis of human salivary immunoglobulins, nonimmune antimicrobial factors, and microflora after tonsillectomy. Clin Immunol Immunopathol1996; 80: 110–115.
22.
Van DalenCJWhitehouseMWWinterbournCC. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J1997; 327: 487–492.
23.
MiyasakiKTWilsonMEGencoRJ. Killing of Actinobacillus actinomycetemcomitans by the human neutrophil myeloperoxidase-hydrogen peroxide-chloride system. Infect Immun1986; 53: 161–165.
24.
TenovuoJAnttilaOLumikariM. Antibacterial effect of myeloperoxidase against Streptococcus mutans. Oral Microbiol Immunol1988; 3: 68–71.
25.
LumikariMSoukkaTNurmioS. Inhibition of the growth of Streptococcus mutans, Streptococcus sobrinus and Lactobacillus casei by oral peroxidase systems in human saliva. Archs Oral Biol1991; 36: 155–160.
26.
IhalinRLoimarantaVLenander-LumikariMTenovuoJ. The effects of different (pseudo)halide substrates on peroxidase-mediated killing of Actinobacillus actinomycetemcomitans. J Periodontal Res1998; 33: 421–427.
27.
Lenander-LumikariM. Inhibition of Candida albicans by the peroxidase/SCN-/H2O3 system. Oral Microbiol Immunol1992; 7:315–320.
28.
MikolaHWarisMTenovuoJ. Inhibition of herpes simplex virus type 1, respiratory syncytial virus and echovirus type 11 by peroxidase-generated hypothiocyanite. Antiviral Res1995;26: 161–171.
29.
YamamotoKMiyoshi-KoshioTUtsukiY. Virucidal activity and viral protein modification by myeloperoxidase: A candidate for defense factor of human polymorphonuclear leukocytes against influenza virus infection. J Infect Dis1991; 164:8–14.
30.
KirstiläVLenander-LumikariMSöderlingE. Effects of oral hygiene products containing lactoperoxidase, lysozyme and lactoferrin on the composition of whole saliva and on subjective oral symptoms in patients with xerostomia. Acta Odontol Scand1996; 54: 391–397.
31.
TenovuoJSöderlingE. Chemical aids in the prevention of dental diseases in the elderly. Int Dent J1992; 42: 355–364.
32.
KirstiläVLenander-LumikariMTenovuoJ. Effects of a lactoperoxidase system-containing toothpaste on dental plaque and whole saliva in vivo. Acta Odontol Scand1994;52:346–353.
